Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:11:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:26:32.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of a new study identifier and collaborators, while substantial content regarding the study's purpose, procedures, and eligibility criteria has been removed.
    Difference
    56%
    Check dated 2025-04-16T11:17:27.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 21, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T05:44:30.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 21, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T22:47:18.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page has been updated to include new study dates and details for the Phase II study of Oral Azacitidine in combination with Pembrolizumab for metastatic melanoma, while some previous updates and information have been removed.
    Difference
    2%
    Check dated 2025-02-24T22:40:19.000Z thumbnail image

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.